Abstract
Nocardia species can cause fulminant necrotizing cavitary pneumonia. Diagnosis involves identification of the organism, speciation, and correlating with appropriate clinical and radiological findings. Speciation is often difficult due to the complexities involved in culturing the organism. Treatment involves administering antibiotics for a prolonged duration. The authors hereby report a case of pulmonary nocardiosis in a patient who had pre-morbidities such as cirrhosis of the liver and membrano-proliferative glomerular nephritis on immunosuppression with high dose corticosteroids making him vulnerable to the organism.
| Original language | English |
|---|---|
| Pages (from-to) | 5-6 |
| Number of pages | 2 |
| Journal | Asian Journal of Pharmaceutical and Clinical Research |
| Volume | 9 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 01-11-2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmaceutical Science
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Fibrous cavity in an immunocompromised lung: Nocardiosis masquerading as tuberculosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver